ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Federal Court Rules In Favor Of Boston Scientific In J&J Patent Case

DOW JONES NEWSWIRES A federal court ruled a stent system made by Boston Scientific Corp. (BSX) doesn't infringe on Johnson & Johnson (JNJ) patents, a judgment that helps the medical-device maker notch a win in a patent war with the health-care products giant. Johnson & Johnson had alleged in a 2008 suit that Boston Scientific's Promus everolimus-eluting coronary stent system infringed on two of its patents. Boston Scientific on Monday touted a decision from a federal court in New Jersey, saying the court had found the patents to be invalid. "Boston Scientific will continue to vigorously defend against any claims of infringement," said Tim Pratt, general counsel for the company. A spokeswoman for Johnson & Johnson couldn't immediately be reached for comment. The two companies have been locked in a long-running battle over intellectual property for heart stents, with both scoring some victories along the way. Johnson & Johnson shares were recently down slightly to $65.25 premarket, while Boston Scientific were up 1.2% to $6.05. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Boston Scientific (BSX)
DateTimeHeadline
02/04/201409:10:31Boston Scientific 4Q Profit Rises 80%
11/15/201309:19:36Omega Advisors 3Q 13F: Holdings As Of Sep 30
11/15/201309:19:36Omega Advisors 3Q 13F: Largest Sales
11/15/201309:01:33HBK Investments LP 3Q 13F: Holdings As Of Sep 30 -2-
11/15/201309:01:33HBK Investments LP 3Q 13F: Holdings As Of Sep 30
11/15/201308:53:17D. E. Shaw & Co. LP 3Q 13F: Holdings As Of Sep 30 -2-
11/15/201308:53:17D. E. Shaw & Co. LP 3Q 13F: Holdings As Of Sep 30
11/15/201308:12:57Fidelity Management & Research Co. 3Q 13F: Holdings As Of Sep...
11/15/201308:12:57Fidelity Management & Research Co. 3Q 13F: -2-
11/15/201307:11:08AQR Capital Management 3Q 13F: Holdings As Of Sep -2-
11/15/201307:11:08AQR Capital Management 3Q 13F: Holdings As Of Sep 30
11/15/201307:10:27AQR Capital Management 3Q 13F: Largest Purchases -2-
11/15/201307:10:23AQR Capital Management 3Q 13F: Largest Sales
11/15/201307:07:21Two Sigma Investments 3Q 13F: Holdings As Of Sep 30
11/15/201307:07:21Two Sigma Investments 3Q 13F: Holdings As Of Sep -2-
11/14/201307:21:25GAMCO Asset Management Inc. 3Q 13F: Largest -2-
11/14/201307:21:24GAMCO Asset Management Inc. 3Q 13F: Largest Sales
11/14/201307:21:23GAMCO Asset Management Inc. 3Q 13F: Holdings As -2-
11/14/201307:21:23GAMCO Asset Management Inc. 3Q 13F: Holdings As Of Sep 30
11/14/201307:19:32The Vanguard Group 3Q 13F: Largest Purchases -2-

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad